ProteoMediX

Exited

Identification of novel biomarkers for the early detection of cancer

Total raised

€10M

€10,200,000

Funding rounds

Investors

distinct backers

Active since

2011-12

latest 2016-07

Funding by year

EUR raised per year

4 rounds

Date	Stage	Amount	Investors
2016-08-01	Series C	€4.6M	Altos Ventures	View deal →
2015-01-01	Series B	€900k	—	View deal →
2014-04-01	Series B	€2.6M	—	View deal →
2012-01-01	Series A	€2.1M	—	View deal →

Type

acquisition

Date

Dec 2023

Value

—

Acquiror

Blue Water Biotech (United States of America)

same sector or country